These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9918902)

  • 1. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation.
    Brady JD; Ju J; Robins SP
    Clin Sci (Lond); 1999 Feb; 96(2):209-15. PubMed ID: 9918902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.
    Cloos PA; Fledelius C
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):473-80. PubMed ID: 10642504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Bonde M; Garnero P; Fledelius C; Qvist P; Delmas PD; Christiansen C
    J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
    Fledelius C; Johnsen AH; Cloos PA; Bonde M; Qvist P
    J Biol Chem; 1997 Apr; 272(15):9755-63. PubMed ID: 9092508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P
    Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover.
    Gineyts E; Cloos PA; Borel O; Grimaud L; Delmas PD; Garnero P
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):481-5. PubMed ID: 10642505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
    Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
    Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone.
    Eriksen HA; Sharp CA; Robins SP; Sassi ML; Risteli L; Risteli J
    Bone; 2004 Apr; 34(4):720-7. PubMed ID: 15050904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies.
    Lung FD; Chen CH; Liou CC; Chen HY
    J Pept Res; 2004 Apr; 63(4):365-70. PubMed ID: 15102054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
    Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
    Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of biologically uncommon D-beta-aspartate-containing alphaA-crystallin in human eye lens.
    Fujii N; Shimo-Oka T; Ogiso M; Momose Y; Kodama T; Kodama M; Akaboshi M
    Mol Vis; 2000 Feb; 6():1-5. PubMed ID: 10706893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterotrimeric type I collagen C-telopeptide conformation as docked to its helix receptor.
    Malone JP; Veis A
    Biochemistry; 2004 Dec; 43(49):15358-66. PubMed ID: 15581348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Echevarría M; Ros I; Ballesta AM; Muñoz-Gómez J
    J Bone Miner Metab; 2002; 20(2):116-20. PubMed ID: 11862534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.